
Lavisodium V 133mg/58mg Tablet
Marketer
Lavish Biotech
Salt Composition
Sodium Valproate (133mg) + Valproic Acid (58mg)
Overview Lavisodium V 133mg/58mg Tablet
Epileptic seizures are managed with the dual-action medication, Lavisodium V 133mg/58mg Tablets. This formulation controls excessive brain activity, calming nerve function to prevent seizure recurrence. Administer this medication with food, following your physician's prescribed dosage regimen, which may be gradually increased for optimal control. Therapeutic effects typically manifest after several weeks of consistent use; therefore, uninterrupted intake is crucial unless your doctor directs otherwise. Cessation could trigger increased seizure frequency or exacerbate any existing bipolar disorder. Common side effects include nausea and tremors, although vomiting, headache, liver impairment, and upper abdominal pain are also possible. Most side effects resolve spontaneously, but persistent or bothersome symptoms warrant medical consultation. Preventive or mitigating strategies may be available. Prior to commencing treatment, disclose any pre-existing kidney or liver conditions, meningitis, depression, or suicidal ideation. Comprehensive medication disclosure is essential, encompassing all concurrently used medications, including oral contraceptives, as interactions are possible. While use during pregnancy or breastfeeding is conditional on necessity and may require dosage adjustments, it’s crucial to discuss this with your doctor. Refrain from driving or cycling if drowsiness or dizziness occur. Regular blood tests monitor treatment efficacy. Avoid alcohol consumption as it may intensify side effects. Weight gain is a potential consequence; maintain a balanced diet, limit high-calorie snacks, and incorporate regular exercise. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal thoughts or actions immediately to your physician.
Primary Ingredients of Lavisodium V 133mg/58mg Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Lavisodium V 133mg/58mg Tablet
Seizure disorder
Major Benefits of Lavisodium V 133mg/58mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Lavisodium V 133mg/58mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Lavisodium V 133mg/58mg Tablet:
- Nausea
- Tremors
How to use Lavisodium V 133mg/58mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Lavisodium V 133mg/58mg Tablets with food.
How Lavisodium V 133mg/58mg Tablet works:
Each Lavisodium V 133mg/58mg tablet contains valproic acid and sodium valproate, a dual anticonvulsant formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Lavisodium V 133mg/58mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals should avoid Lavisodium V 133mg/58mg tablets due to confirmed risks to the fetus. Exceptions may exist in life-threatening emergencies where a physician deems the potential benefits outweigh the hazards. Always seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Lavisodium V 133mg/58mg Tablets without safety concerns. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Taking Lavisodium V 133mg/58mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Lavisodium V 133mg/58mg tablets in patients with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary, but a physician's consultation is recommended, particularly if kidney disease is present.
LiverCAUTION
Patients with liver impairment should use Lavisodium V 133mg/58mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Lavisodium V 133mg/58mg Tablet :
Should you forget a Lavisodium V 133mg/58mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lavisodium V 133mg/58mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
